# Inaugural Conference on Implementation Science for Cancer Control in Africa (ISC2-Africa)

> **NIH NIH R13** · MAYO CLINIC  JACKSONVILLE · 2021 · $15,000

## Abstract

PROJECT SUMMARY
According to the World Health Organization, morbidity and mortality from non-communicable diseases in Africa
will surpass that of communicable diseases by 2030. While Africa faces several challenges in controlling cancer,
the field of Implementation Science (IS) offers a ray of hope for cancer control in Africa. Defined as the “study of
methods to promote the adoption and integration of evidence-based practices, interventions, and policies into
routine health care and public health settings to improve the impact on population health”, IS is crucial to address
the disproportionate burden of cancer in Africa. Unfortunately, Africa does not have the much needed research
workforce for IS. The African Organization for Research and Training in Cancer (AORTIC), African
Behavioral Research (ABeR) Center, Africa Cancer ECHO, and International Cancer Research
Partnership (ICRP) have partnered to create an Implementation Science for Cancer Control in Africa (ISC2-
Africa) Network. We are proposing an ISC2-Africa inaugural conference to be held biennially as a pre-
conference to the AORTIC International Cancer Conference. The primary goal of the ISC2-Africa conference is
to elevate IS scholarship in Africa. In addition, we will develop an African IS workforce that will bring unique
perspective to addressing cancer control in Africa as well as effectively deliver and integrate cancer control
interventions within the Africa health care systems and communities. Utilizing an innovative framework, the
conference will foster: (1) the mobilization of resources within African countries for Afro-centric IS strategies; (2)
partnership with key stakeholders for effective and culturally appropriate IS research; and (3) the development
and successful implementation of IS research across Africa. A cornerstone of our conference -- and we believe
the most innovative aspect-- is that the final conference agenda is based on the needs identified by cancer
scientists and clinicians in Africa through a SWOT Analysis survey.

## Key facts

- **NIH application ID:** 10318327
- **Project number:** 1R13CA265019-01
- **Recipient organization:** MAYO CLINIC  JACKSONVILLE
- **Principal Investigator:** FOLAKEMI T ODEDINA
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $15,000
- **Award type:** 1
- **Project period:** 2021-09-08 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10318327

## Citation

> US National Institutes of Health, RePORTER application 10318327, Inaugural Conference on Implementation Science for Cancer Control in Africa (ISC2-Africa) (1R13CA265019-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10318327. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*